AusCann Group Holdings (ASX:AC8) 1H18 results

Interviews

by Jessica Amir

AusCann Group Holdings Limited (ASX:AC8) Managing Director, Elaine Darby provides an update on the company's significant progress with its supply chain, industry outreach program and regulatory progress.


AusCann (ASX:AC8) is the only ASX listed company with all the necessary licences required to grow and manufacture medical cannabis. It's bringing together leading expertise and operations across all aspects of the medical cannabis value chain, beginning with cultivation and production, through to manufacture and distribution of products.

AusCann Managing Director, Elaine Darby says they welcome the decision of the Australian Government to allow the export of medical cannabis out of Australia.

They invested over $2 million in cash and over $2.7 million in share based payments in H1 financial year on research and development. They ended the year with over $12.3 million cash in the bank.

To learn more, listen to our interview with AusCann Managing Director, Elaine Darby.  

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.